VYLDA P 15/50 is a Fixed Dose Combination medication containing Vildagliptin (50.00mg/Tablet) and Pioglitazone (15.00mg/Tablet). This combination is used to improve glycemic control in patients with type 2 diabetes mellitus. This combination medication offers a comprehensive approach to managing diabetes and helps reduce the risk of complications associated with uncontrolled blood sugar levels.

• Treatment of type 2 diabetes mellitus
• Improvement of glycemic control
• Reduction of HbA1c levels

• Headache
• Hypoglycemia (low blood sugar)
• Weight gain
• Upper respiratory tract infection
• Edema (fluid retention)

Take VYLDA P 15/50 orally according to the dosage and frequency prescribed by your doctor. It is usually taken with or without food. Do not change the dose or stop taking the medication without consulting your healthcare provider.

• Pregnancy - VYLDA P 15/50 is not recommended during pregnancy. Consult your doctor for safer alternative treatments.
• Alcohol - Limit alcohol consumption while taking VYLDA P 15/50 as it may affect blood sugar levels.
• Old Age - No specific precautions are required for elderly patients using VYLDA P 15/50, but monitoring for hypoglycemia is recommended.
• Breast Feeding - It is not recommended to use VYLDA P 15/50 while breastfeeding. Consult your healthcare provider for alternative options.
• Children - The safety and efficacy of VYLDA P 15/50 have not been established in pediatric patients. Consult a pediatric endocrinologist for suitable treatment options.

• Store VYLDA P 15/50 at room temperature (20-25°C) in a cool, dry place. -
• Keep away from direct sunlight and moisture. -

• Drug-Drug - Some medications like insulin or other antidiabetic agents may interact with VYLDA P 15/50. Inform your doctor about all medications you are taking.
• Drug-Food - Certain foods and beverages may interact with VYLDA P 15/50 and affect blood sugar levels. Consult with a healthcare provider for dietary advice.
• Drug-Disease - Patients with heart failure, liver disease, or a history of bladder cancer should use VYLDA P 15/50 with caution. Regular monitoring is essential for these conditions.

• Q. Can VYLDA P 15/50 cure diabetes?
  VYLDA P 15/50 helps manage diabetes by controlling blood sugar levels, but it does not cure the disease. It is important to continue taking the medication as prescribed by your healthcare provider.
• Q. What should I do if I miss a dose of VYLDA P 15/50?
  If you miss a dose, take it as soon as you remember. However, if it is almost time for the next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.
• Q. Can VYLDA P 15/50 cause hypoglycemia?
  Yes, VYLDA P 15/50 can lower blood sugar levels and may cause hypoglycemia, especially when combined with other antidiabetic medications. Monitor your blood sugar levels regularly and be aware of the signs and symptoms of low blood sugar.
• Q. Is it safe to drive while taking VYLDA P 15/50?
  VYLDA P 15/50 may cause dizziness or drowsiness in some individuals. If you experience these side effects, avoid driving or operating machinery until you are sure you can do so safely.
• Q. Can VYLDA P 15/50 be used in patients with kidney disease?
  Patients with kidney disease may require dose adjustments or closer monitoring when using VYLDA P 15/50. Consult a nephrologist for personalized treatment recommendations.